Table 2 Time to onset of Pexidartinib-associated adverse events and Weibull distribution analysis.

From: A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system

Drug

TTO(Days)

Weibull distribution

Case reports

Median (d) (lQR)

Scale parameter: α(95%Cl)

Shape parameter: β(95%Cl)

Type

Pexidartinib

107

35 (14–94)

96.41 (63.10–129.73)

0.65 (0.54–0.75)

Early failure

  1. TTO, Time to onset; Cl, Contrialfdence interval; IQR, Interquartile range.
Back to article page